Cargando…

Activation of the PI3K/mTOR Pathway Is Involved in Cystic Proliferation of Cholangiocytes of the PCK Rat

The polycystic kidney (PCK) rat is an animal model of Caroli’s disease as well as autosomal recessive polycystic kidney disease (ARPKD). The signaling pathways involving the mammalian target of rapamycin (mTOR) are aberrantly activated in ARPKD. This study investigated the effects of inhibitors for...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Xiang Shan, Sato, Yasunori, Harada, Kenichi, Sasaki, Motoko, Furubo, Shinichi, Song, Jing Yu, Nakanuma, Yasuni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907540/
https://www.ncbi.nlm.nih.gov/pubmed/24498161
http://dx.doi.org/10.1371/journal.pone.0087660
_version_ 1782301619134660608
author Ren, Xiang Shan
Sato, Yasunori
Harada, Kenichi
Sasaki, Motoko
Furubo, Shinichi
Song, Jing Yu
Nakanuma, Yasuni
author_facet Ren, Xiang Shan
Sato, Yasunori
Harada, Kenichi
Sasaki, Motoko
Furubo, Shinichi
Song, Jing Yu
Nakanuma, Yasuni
author_sort Ren, Xiang Shan
collection PubMed
description The polycystic kidney (PCK) rat is an animal model of Caroli’s disease as well as autosomal recessive polycystic kidney disease (ARPKD). The signaling pathways involving the mammalian target of rapamycin (mTOR) are aberrantly activated in ARPKD. This study investigated the effects of inhibitors for the cell signaling pathways including mTOR on cholangiocyte proliferation of the PCK rat. Cultured PCK cholangiocytes were treated with rapamycin and everolimus [inhibitors of mTOR complex 1 (mTOC1)], LY294002 [an inhibitor of phosphatidylinositol 3-kinase (PI3K)] and NVP-BEZ235 (an inhibitor of PI3K and mTORC1/2), and the cell proliferative activity was determined in relation to autophagy and apoptosis. The expression of phosphorylated (p)-mTOR, p-Akt, and PI3K was increased in PCK cholangiocytes compared to normal cholangiocytes. All inhibitors significantly inhibited the cell proliferative activity of PCK cholangiocytes, where NVP-BEZ235 had the most prominent effect. NVP-BEZ235, but not rapamycin and everolimus, further inhibited biliary cyst formation in the three-dimensional cell culture system. Rapamycin and everolimus induced apoptosis in PCK cholangiocytes, whereas NVP-BEZ235 inhibited cholangiocyte apoptosis. Notably, the autophagic response was significantly induced following the treatment with NVP-BEZ235, but not rapamycin and everolimus. Inhibition of autophagy using siRNA against protein-light chain3 and 3-methyladenine significantly increased the cell proliferative activity of PCK cholangiocytes treated with NVP-BEZ235. In vivo, treatment of the PCK rat with NVP-BEZ235 attenuated cystic dilatation of the intrahepatic bile ducts, whereas renal cyst development was unaffected. These results suggest that the aberrant activation of the PI3K/mTOR pathway is involved in cystic proliferation of cholangiocytes of the PCK rat, and inhibition of the pathway can reduce cholangiocyte proliferation via the mechanism involving apoptosis and/or autophagy.
format Online
Article
Text
id pubmed-3907540
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39075402014-02-04 Activation of the PI3K/mTOR Pathway Is Involved in Cystic Proliferation of Cholangiocytes of the PCK Rat Ren, Xiang Shan Sato, Yasunori Harada, Kenichi Sasaki, Motoko Furubo, Shinichi Song, Jing Yu Nakanuma, Yasuni PLoS One Research Article The polycystic kidney (PCK) rat is an animal model of Caroli’s disease as well as autosomal recessive polycystic kidney disease (ARPKD). The signaling pathways involving the mammalian target of rapamycin (mTOR) are aberrantly activated in ARPKD. This study investigated the effects of inhibitors for the cell signaling pathways including mTOR on cholangiocyte proliferation of the PCK rat. Cultured PCK cholangiocytes were treated with rapamycin and everolimus [inhibitors of mTOR complex 1 (mTOC1)], LY294002 [an inhibitor of phosphatidylinositol 3-kinase (PI3K)] and NVP-BEZ235 (an inhibitor of PI3K and mTORC1/2), and the cell proliferative activity was determined in relation to autophagy and apoptosis. The expression of phosphorylated (p)-mTOR, p-Akt, and PI3K was increased in PCK cholangiocytes compared to normal cholangiocytes. All inhibitors significantly inhibited the cell proliferative activity of PCK cholangiocytes, where NVP-BEZ235 had the most prominent effect. NVP-BEZ235, but not rapamycin and everolimus, further inhibited biliary cyst formation in the three-dimensional cell culture system. Rapamycin and everolimus induced apoptosis in PCK cholangiocytes, whereas NVP-BEZ235 inhibited cholangiocyte apoptosis. Notably, the autophagic response was significantly induced following the treatment with NVP-BEZ235, but not rapamycin and everolimus. Inhibition of autophagy using siRNA against protein-light chain3 and 3-methyladenine significantly increased the cell proliferative activity of PCK cholangiocytes treated with NVP-BEZ235. In vivo, treatment of the PCK rat with NVP-BEZ235 attenuated cystic dilatation of the intrahepatic bile ducts, whereas renal cyst development was unaffected. These results suggest that the aberrant activation of the PI3K/mTOR pathway is involved in cystic proliferation of cholangiocytes of the PCK rat, and inhibition of the pathway can reduce cholangiocyte proliferation via the mechanism involving apoptosis and/or autophagy. Public Library of Science 2014-01-30 /pmc/articles/PMC3907540/ /pubmed/24498161 http://dx.doi.org/10.1371/journal.pone.0087660 Text en © 2014 Ren et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Ren, Xiang Shan
Sato, Yasunori
Harada, Kenichi
Sasaki, Motoko
Furubo, Shinichi
Song, Jing Yu
Nakanuma, Yasuni
Activation of the PI3K/mTOR Pathway Is Involved in Cystic Proliferation of Cholangiocytes of the PCK Rat
title Activation of the PI3K/mTOR Pathway Is Involved in Cystic Proliferation of Cholangiocytes of the PCK Rat
title_full Activation of the PI3K/mTOR Pathway Is Involved in Cystic Proliferation of Cholangiocytes of the PCK Rat
title_fullStr Activation of the PI3K/mTOR Pathway Is Involved in Cystic Proliferation of Cholangiocytes of the PCK Rat
title_full_unstemmed Activation of the PI3K/mTOR Pathway Is Involved in Cystic Proliferation of Cholangiocytes of the PCK Rat
title_short Activation of the PI3K/mTOR Pathway Is Involved in Cystic Proliferation of Cholangiocytes of the PCK Rat
title_sort activation of the pi3k/mtor pathway is involved in cystic proliferation of cholangiocytes of the pck rat
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907540/
https://www.ncbi.nlm.nih.gov/pubmed/24498161
http://dx.doi.org/10.1371/journal.pone.0087660
work_keys_str_mv AT renxiangshan activationofthepi3kmtorpathwayisinvolvedincysticproliferationofcholangiocytesofthepckrat
AT satoyasunori activationofthepi3kmtorpathwayisinvolvedincysticproliferationofcholangiocytesofthepckrat
AT haradakenichi activationofthepi3kmtorpathwayisinvolvedincysticproliferationofcholangiocytesofthepckrat
AT sasakimotoko activationofthepi3kmtorpathwayisinvolvedincysticproliferationofcholangiocytesofthepckrat
AT furuboshinichi activationofthepi3kmtorpathwayisinvolvedincysticproliferationofcholangiocytesofthepckrat
AT songjingyu activationofthepi3kmtorpathwayisinvolvedincysticproliferationofcholangiocytesofthepckrat
AT nakanumayasuni activationofthepi3kmtorpathwayisinvolvedincysticproliferationofcholangiocytesofthepckrat